News
CDMO
6.70
-4.01%
-0.28
Weekly Report: what happened at CDMO last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at CDMO last week (0311-0315)?
Weekly Report · 03/18 09:42
Avid Bioservices Inc <CDMO.OQ> expected to post a loss of 5 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 5 cents a share - Earnings Preview. The company is expected to report a 12.0% decrease in quarterly revenue to $33.452 million.
Reuters · 03/15 21:24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
Glancy Prongay & Murray LLP has commenced an investigation on behalf of Avid Bioservices, Inc. Investors concerning the Company’s possible violations of the federal securities laws. On March 6, 2024, Avid disclosed that it received an acceleration notice from a holder of its senior notes. Avid's stock price fell 30.6% on March 7, 2024.
Barchart · 03/14 13:12
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Avid Bioservices, Inc. Investors concerning the Company’s possible violations of federal securities laws. On March 6, 2024, Avid disclosed that it received an acceleration notice from a holder of its 1.250% Exchangeable Senior Notes due 2026. The Company also disclosed it may be unable to timely file its first quarter 2024 financial results. Avid's stock price fell $2.69, or 30.6%, on March 7, 2024.
Barchart · 03/13 19:36
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Avid Bioservices, Inc. On behalf of investors. Avid’s stock price fell $2.69, or 30.6%, to close at $6.10 per share on March 7, 2024. The Company received an acceleration notice of possible violations of federal securities laws.
Barchart · 03/13 13:40
Avid Bioservices Is Maintained at Overweight by Stephens & Co.
Dow Jones · 03/11 15:10
Avid Bioservices Price Target Cut to $12.00/Share From $15.00 by Stephens & Co.
Dow Jones · 03/11 15:10
Stephens & Co. Maintains Overweight on Avid Bioservices, Lowers Price Target to $12
Benzinga · 03/11 15:00
Weekly Report: what happened at CDMO last week (0304-0308)?
Weekly Report · 03/11 09:41
Avid Bioservices Faces Financial Strain Amid Market Challenges  (Rating Downgrade)
Avid Bioservices' stock plummeted 30% post-earnings. Q3 revenue fell 11%, with significant drops in gross margin and operating income. Company announced planned $160 million 7.00% Convertible Senior Notes; default on 2026 Notes triggers cross-default, complicating finances. Downgrade to strong sell due to financial instability, eroding trust, and competitive market pressures.
Seeking Alpha · 03/08 12:00
Avid Bioservices Inc <CDMO.OQ> expected to post a loss of 6 cents a share - Earnings Preview
Avid Bioservices Inc expected to post a loss of 6 cents a share - Earnings Preview. The company is expected to report a fall in quarterly revenue to $33.594 million from $38.02 million.
Reuters · 03/08 11:11
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
TipRanks · 03/08 01:46
Avid Bioservices Down Over 29%, on Pace for Largest Percent Decrease Since February 2016 -- Data Talk
Avid Bioservices, Inc. Is currently at $6.18, down $2.61 or 29.69% from yesterday's close. Down 98.74% from its all-time closing high of $490.00 on March 7, 2000. Down 19.53% month-to-date.
Dow Jones · 03/07 19:56
S&P 500 Gains 1%; Kroger Earnings Top Views
U.S. Stocks traded higher toward the end of trading on Thursday. The Dow traded up 0.34% to 38,793.79 while the NASDAQ rose 1.63%. Kroger Company reported better-than-expected earnings for its fourth quarter. Lytus Technologies shares shot up 348% to $10.34 after the company announced the launch of a new cloud service.
Benzinga · 03/07 19:31
BUZZ-U.S. STOCKS ON THE MOVE-Teladoc Health, Hamilton Insurance, SciSparc
Wall Street's main indexes gained on Thursday. Dow Jones Industrial Average was up 0.50% at 38,855.19. Federal Reserve chair Jerome Powell said the central bank still expects to cut rates later this year. The top three S&P 500 percentage gainers were ON Semiconductor, The Kroger. Victoria's Secret & Co. Was the biggest loser.
Reuters · 03/07 19:02
Biotech/Pharma Contract Service Provider Avid Bioservices Sees Lower Than Expected Q3 Sales, Sticks To Annual Guidance
Avid Bioservices Inc reported preliminary revenues for the third quarter of fiscal 2024 of $33.8 million. The company completed its cell and gene therapy facility. Avid has a revenue backlog of $206 million, representing an increase of 17%. The company maintains fiscal year 2024 revenue of $137 million-$147 million.
Benzinga · 03/07 18:40
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
HighPeak Energy, Inc. Shares fell 15.3% to $13.49 on Thursday. The company reported worse-than-expected fourth-quarter revenue results. Lytus Technologies Holdings PTV. Ltd. Shares jumped 404% in the mid-day session.
Benzinga · 03/07 18:35
Dow Gains 100 Points; Victoria's Secret Shares Plunge
U.S. Stocks traded higher midway through trading on Thursday. The Nasdaq Composite gained over 1% and the Dow traded up 0.26%. The Dow and S&P 500 were both up over 1%. BJ's Wholesale Club reported downbeat sales for its fourth quarter.
Benzinga · 03/07 17:35
12 Health Care Stocks Moving In Thursday's Intraday Session
Psyence Biomedical stock moved upwards by 35.3% to $1.38 during Thursday's regular session. HeartBeam stock rose 26.53% and Ocean Biomedical shares increased by 24.4% during the session. Losers Avid Bioservices stock fell 31.2% and Aptorum Gr stock decreased by 31.3%.
Benzinga · 03/07 17:31
More
Webull provides a variety of real-time CDMO stock news. You can receive the latest news about Avid Bioservices through multiple platforms. This information may help you make smarter investment decisions.
About CDMO
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services. The Company’s services include clinical and commercial product manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The Company also provides a variety of process development services, including upstream and downstream development and optimization, analytical methods development, testing and characterization. It provides fully integrated and customized biomanufacturing services that support its customers from the early preclinical stage to commercial launch and supply.